Archives: Contractor Email

Dear Colleague

Please find correspondence HERE from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

SUMMARY

• HSCB is seeking completion of the Community Pharmacy Assurance Framework (CPAF) declaration form for your pharmacy, for the 2021/2022 year.
• The aim and purpose of the framework is to monitor compliance with Terms of Service, service specifications, related professional standards and best practice guidance.
• HSCB has recently worked with CPNI to review, update and agree the Assurance framework for the 2021/22 year.
• A payment of £1200 will be made to each pharmacy, upon return of the completed declaration, for compliance with the CPAF process in 2021/22.

ACTION

• Contractors are asked to review the correspondence.
• Complete and return the individual prepopulated declaration form which you will have received by secure email. Please submit a return for each pharmacy you operate, to your local HSCB office via email by Monday 28 February 2022.
• You are also required to submit a copy of your practice leaflet and complaints procedure.
• CPNI have produced a guidance document and resources to support you with this submission, including a template practice leaflet, available on CPNI’s website HERE.
• Please do not hesitate to contact your local Local Integrated Care Offices or the CPNI office should you require any further information.

Kind regards

Dear Colleague

Please find attached correspondence HERE from HSCB Pharmacy and Medicines Management team.

SUMMARY

• Overall demand has reduced over the past number of weeks but that pharmacies in some areas continue to experience high demand, with some regularly running out between deliveries or having to ration the number of packs given per transaction to extend their supplies.
• There now exists capacity, under the current arrangements, to allow those pharmacies experiencing ongoing high demand to submit a request to receive a larger order (2-3 cartons).
• If demand at your pharmacy is at a consistently high level and you would like to request a fixed, ongoing increase please state this within the email request and we will work with UKHSA and Alliance to see if this can be accommodated.

ACTION

• Contractors are asked to review the correspondence.
• If you would like to arrange this for your pharmacy please email is LFDtests@health-ni.gov.uk
• Please state clearly;
  • Name of pharmacy
  • Pharmacy Address
  • Alliance Account Code
  • indicate if you would like to request an order or 2 or 3 cartons.
• Please do not hesitate to contact your local HSCB office or the CPNI office should you require any further information.

Kind regards

Tuesday 22 February 2022

Dear Colleague As you will be aware, the Pharmacy First for Winter Conditions Service commenced in November 2021 and will be concluding at the end of March 2022. The key aims of the service are to promote the role of the community pharmacy as the first port of call for the management of Winter Conditions, and to displace activity, including consultations, advice and prescribing from general practice to community pharmacy.  For those pharmacies providing the service this year, it is important to remember that the following records are to be returned: 1. The completed monthly activity form – The form can be accessed here and should include the details of all Pharmacy First Winter Conditions consultations conducted throughout the month.  It should be scanned and returned by email each month to the local HSCB office.  2. The completed PV1 forms – These should be bundled separately and returned to BSO in the second monthly prescription submission. Returning both of these elements, i.e. the PV1 forms and the monthly activity form is an essential part of the service contract and the data they provide will help secure the commissioning of future Pharmacy First Services for Winter Conditions.  The monthly activity form demonstrates the many Pharmacy First activities which are not captured through the PV1 forms alone. For example, the monthly activity form provides data on the number of consultations carried out in which medicine supply was not necessary or appropriate, instead advice was provided, a referral made, or an alternative treatment was purchased. Failure to demonstrate the impact of community pharmacy via this service may mean we will be unable to secure funding for this service next year. CPNI appreciates it has been an incredibly busy few months for pharmacy teams, but it is vital the service returns are made monthly to demonstrate the value of Pharmacy First to the Health Service. Resources to help promote the service within your pharmacy are available here. As always, should you require any further help or assistance please do not hesitate to get in touch with the CPNI team.

Kind regards Ennis Ennis Shields CPNI Governance and Service Support Pharmacist

Dear Colleague

The Health and Social Care Board, in collaboration with the Department of Health and CPNI, is developing a Pharmacy First Service for emergency hormonal contraception (EHC).  

All community pharmacists are invited to attend an ECHO training event tonight, Monday 21 February 2022 at 7.30pm.

Further details are available in the letter of invite which can be accessed by clicking HERE.

Kind regards

This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS 

• Weekly Drug Alerts are available here.
  • Medicines Recall – Fluorouracil Injection, 50 mg/ml 18 February 2022
  • Medicines Recall – Efudix 5% cream 17 February 2022
  • Medicines Recall – Water for Injection 100ml vial 15 February 2022
• Weekly Shortages Information is available here.
  • Atorvastatin (Lipitor) 10mg and 20mg chewable tablets 15 February 2022
  • Piroxicam (Feldene Melt) 20mg orodisp tablets 15 February 2022
  • Ciprofloxacin 0.3% / Dexamethasone 0.1% ear drops 15 February 2022
  • Locorten Vioform ® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solution 15 February 2022
• Serious Shortage Protocols are available here.

CPNI ALERTS 

• Reminder Pharmacy First Winter Conditions 8 November 2021
• Second Concessionary Prices – February 2022 17 February 2022
• Pharmacy First Service For Emergency Hormonal Contraception (EHC) 17 February 2022
• Guidance On Wearing Face Coverings 17 February 2022
• HSC Quality Improvement Awards 2022 15 February 2022
• First Concessionary Prices – February 2022 15 February 2022
• HSCB Community Pharmacy Remuneration Consultation 2022/2023 CPNI Proposed Response 15 February 2022

HSCB ALERTS 

• Opioid Substitution Therapy (OST) Community Pharmacy Service – Additional 6 Day Provision Required in the Lisburn Area 16 February 2022
• Substitute Prescribing Patient Registration System 16 February 2022
• New Pharmacy First Service for Emergency Hormonal Contraception (EHC) 16 February 2022
• Prescribing Update: Management of Lactose Intolerance and Reflux in Infants – Letter and Guidance for Community Pharmacists and General Practitioners 16 February 2022
• Prescribing Infant Formula for Mild to Moderate Non-IgE Mediated Cows Milk Allergy 15 February 2022
• Stakeholder Engagement Invitation – Managing Cow’s Milk Allergy in infants and children 14 February 2022

Please bring this to the attention of your pharmacy team(s). Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and the Contractor Emails.

Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter or Situation Reporter.

Kind regards

Dear Colleague

The second update of concessionary prices were granted for February 2022:

Drug	Pack Size	Concessionary Price
Amisulpride 100mg tablets	60	£4.89
Amisulpride 200mg tablets	60	£6.00
Amisulpride 50mg tablets	60	£2.93
Amoxicillin 500mg capsules	15	£1.25
Amoxicillin 500mg capsules	21	£.175
Celecoxib 100mg capsules	60	£8.94
Celecoxib 200mg capsules	30	£8.39
Cinnarizine 15mg tablets	84	£3.88
Clarithromycin 250mg tablets	14	£1.25
Clarithromycin 500mg tablets	14	£1.97
Clomipramine 10mg capsules	28	£2.32
Clomipramine 25mg capsules	28	£4.99
Cyanocobalamin 50microgram tablets	50	£14.49
Cyclizine 50mg/1ml solution for injection ampoules	5	£6.45
Dexamethasone 2mg tablets	50	£3.99
Dosulepin 75mg tablets	28	£11.20
Enalapril 10mg tablets	28	£3.75
Enalapril 5mg tablets	28	£5.75
Famotidine 40mg tablets	28	£27.00
Fenofibrate micronised 160mg tablets	28	£4.01
Fenofibrate micronised 200mg capsules	28	£2.50
Hydroxocobalamin 1mg/1ml solution for injection ampoules	5	£5.07
Ibuprofen 100mg/5ml oral suspension sugar free	100	£3.14
Isotretinoin 20mg capsules	30	£12.46
Ivabradine 2.5mg tablets	56	£25.33
Lamotrigine 5mg dispersible tablets sugar free	28	£9.38
Lansoprazole 15mg orodispersible tablets	28	£3.08
Lansoprazole 30mg orodispersible tablets	28	£4.50
Losartan 100mg tablets	28	£3.85
Losartan 25mg tablets	28	£2.15
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets	28	£7.15
Losartan 50mg tablets	28	£2.85
Midazolam 10mg/2ml solution for injection ampoules	10	£6.36
Naftidrofuryl 100mg capsules	84	£8.10
Nortriptyline 10mg tablets	100	£2.32
Nortriptyline 25mg tablets	100	£1.82
Orlistat 120mg capsules	84	£24.99
Oxcarbazepine 150mg tablets	50	£12.24
Prasugrel 10mg tablets	28	£6.30
Prasugrel 5mg tablets	28	£34.99
Pravastatin 40mg tablets	28	£1.40
Prednisolone 5mg soluble tablets	30	£9.90
Ropinirole 1mg tablets	84	£46.50
Ropinirole 250microgram tablets	12	£3.25
Ropinirole 2mg tablets	28	£18.47
Ropinirole 500microgram tablets	28	£6.00
Sulfasalazine 500mg gastro-resistant tablets	112	£36.16
Sulfasalazine 500mg tablets	112	£27.30
Tolbutamide 500mg tablets	28	£28.00
Tolterodine 1mg tablets	56	£2.35
Topiramate 100mg tablets	60	£4.39
Topiramate 25mg tablets	60	£2.34
Topiramate 50mg tablets	60	£2.79
Valsartan 40mg capsules	28	£2.95
Valsartan 80mg capsules	28	£5.28
Warfarin 500microgram tablets	28	£1.37

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kind regards